Table 2.
Pathogenic HBB mutations in Pomak and MANOLIS and their associations with red cell distribution width.
| Mutation | rs-id | Consequence | type | Position | Allele frequency | N carriers | Beta* | SE | P-value* |
|---|---|---|---|---|---|---|---|---|---|
| Pomak (N = 1617) | |||||||||
| HbO-Arab c.364G>A (p.Glu122Lys) | rs33946267 | Missense | HbO | 5,225,678 | 0.044 | 139 | − 1.35 | 0.085 | 1.3 × 10–51 |
| IVS-II-745c.316-106C> G | rs34690599 | Splice site | β + | 5,225,832 | 0.004 | 14 | − 2.79 | 0.291 | 4.7 × 10–21 |
| IVS-I-110 c.93-21G>A | rs35004220 | Splice site | β + | 5,226,820 | 0.0003 | 1 | − 2.59 | 0.949 | 0.006 |
| IVS-I-6 c.92 + 6T>C | rs35724775 | Splice site | β + | 5,226,924 | 0.002 | 7 | − 1.99 | 0.383 | 2.3 × 10–7 |
| IVS-I-1 c.92+1G>A | rs33971440 | Splice donor | β0 | 5,226,929 | 0.0003 | 1 | − 2.39 | 0.968 | 0.014 |
| IVS-I (-1) c.92G>A (p.Arg31Lys) | rs33960103 | Missense | β0 | 5,226,930 | 0.0003 | 1 | − 2.40 | 0.908 | 0.008 |
| MANOLIS (N = 1457) | |||||||||
| IVS-II-848 c.316-3C>A | rs33913413 | Splice site | β + | 5,225,729 | 0.0003 | 1 | − 2.12 | 0.991 | 0.033 |
| CD39 c.118C>T (p.Gln40Ter) | rs11549407 | Stop gained | β0 | 5,226,774 | 0.005 | 13 | − 2.06 | 0.285 | 7.4 × 10–13 |
| IVS-I-110 c.93-21G>A | rs35004220 | splice site | β + | 5,226,820 | 0.015 | 44 | − 2.16 | 0.166 | 3.2 × 10–36 |
| IVS-I-6 c.92 + 6T>C | rs35724775 | splice site | β + | 5,226,924 | 0.001 | 3 | − 1.40 | 0.562 | 0.013 |
| CD8/9 + G c.27dupG (p.Ser10Valfs*14) | rs35699606 | frameshift | β0 | 5,226,995 | 0.009 | 23 | − 2.35 | 0.247 | 1.1 × 10–20 |
| c.20A>T (p.Glu7Val) | rs334 | missense | HbS | 5,227,002 | 0.004 | 15 | − 0.79 | 0.342 | 0.021 |
* Regression coefficient beta and p value for the association of the variant with red cell distribution width in units of standard deviation.